`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF NEW JERSEY
`
`)
`)
`)
`
`))
`
`))
`
`) Civil Action No.:
`)
`2:1 5-cv-05909-KM-JBC
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`))
`
`)
`
`BTG INTERNATIONAL LIMITED, JANSSEN
`BIOTECH, INC., JANSSEN ONCOLOGY, INC.,
`JANSSEN RESEARCH & DEVELOPMENT, LLC,
`
`Plaintiffs,
`
`v.
`
`ACTAVIS LABORATORLES FL, INC., AMNEAL
`PHARMACEUTICALS LLC, AMNEAL
`PHARMACEUTICALS OF NEW YORK, LLC,
`APOTEX CORP., APOTEX INC., CITRON PHARMA
`LLC, DR. REDDY’S LABORATORIES, INC., DR.
`REDDY’S LABORATORIES, LTD., MYLAN
`PHARMACEUTICALS INC., MYLAN, [NC., PAR
`PHARMACEUTICAL, INC., PAR
`PHARMACEUTICAL COMPANIES, INC., SUN
`PHARMACEUTICALS INDUSTRIES, LTD., SUN
`PHARMACEUTICALS INDUSTRIES, INC., TEVA
`PHARMACEUTICALS USA, INC., WEST-WARD
`PHARMACEUTICALS CORP., HIKMA
`PHARMACEUTICALS, LLC, WOCKHARDT BIO AG,
`WOCKHARDT USA LLC, WOCKHARDT LTD.,
`HETERO USA [NC., HETERO LABS LIMITED UNIT-
`V, and HETERO LABS LIMITED,
`
`Defendants.
`
`I&OSE’DI ORDER GRANTING JANSSEN’S MOTION TO SET A HEARING AND
`CORRECT INVENTORSHIP OF THE ‘438 PATENT PURSUANT TO 35 U.S.C. § 256
`AND AUTHORIZING THE FILING OF A SECOND AMENDED COMPLAINT
`(€CF no. rre)
`THIS MATTER is before the Court on Janssen’s MotionlTo Correct Inventorship of the
`
`‘438 Patent Pursuant to 35 U.S.C. § 256 (“Motion to Correct Inventorship”).’
`
`As used herein, “Janssen” refers collectively to Plaintiffs Janssen Biotech, Inc. (“Janssen
`Biotech”), Janssen Oncology, Inc. (“Janssen Oncology”), and Janssen Research & Development,
`LLC (“Janssen R&D”). “Plaintiffs” refers collectively to Janssen and Plaintiffs BTG
`International Ltd.
`
`JANSSEN EXHIBIT 2132
`Wockhardt v. Janssen IPR2016-01582
`
`
`
`Case 2:15-cv-05909-KM-JBC Document 270 Filed 01/24/17 Page 2 of 2 PageID: 4471
`
`(EU
`
`aS?1 zg
`
`b $t
`tkt CLiwt cJ( SO(c6( R;b%.tck&Gt Ltc ecLvt’j çf7 4a2 2O(j
`( cc £. 25Sf
`Upon the declaration o’i newly identified inventor Johann S. de Bono dated February 29,
`
`Upon
`
`partic3efloorI4d.,
`
`‘
`
`2016, agreeing to the change in inventorship of the U.S. Patent No. 8,822,438;
`
`Upon the declaration of Gerhardt Attard, dated February 29, 2016, in support of Janssen’s
`
`Motion to Correct Iriventorship;
`
`Upon Janssen’s Memorandum of Law in support of its Motion to Correct Inventorship,
`
`dated March 8, 2016; as well as the pleadings and papers filed herein,
`
`IT IS on this day of
`
`-.JtkCk1, 2016;
`
`ORDERED that Janssen’s Motion To Correct Inventorship Of The ‘438 Patent Pursuant
`
`To 35 U.S.C. § 256 is GRANTED in its entirety,
`
`ORDERED that, pursuant to 35 U.S.C. 256, the Director of the United States Patent and
`
`Trademark Office shall issue a certificate to correct inventorship of U.S. Patent No. 8,822,438 to
`
`include co-inventor, Johann S. de Bono, who was inadvertently not identified as an inventor by
`
`error, and
`
`FURTHER ORDERED that Plaintiffs are granted leave to file afe’id Amended
`
`Complaint.
`
`‘fkt ca’5e lvS.
`
`IT IS SO ORDERED.
`
`HO ORABLE KEVIN MCNULTY
`UNiTED STATES DISTRICT JUDGLJ
`
`2
`
`